Skip to content
Modifi Bio logo — Modifying DNA to Eradicate Cancer

Modifi Bio

Modifying DNA to Eradicate Cancer

Founded 2021 10 employees Seed Total: $13.10M Biotechnology, Health and Wellness

General Information

Company Name Modifi Bio
Founded Year 2021
Employees 10
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Modifi Bio. To contact Modifi Bio, visit modifibio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Modifi Bio compare?

A PDF of Modifi Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Modifi Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Modifi Bio

Modifi Bio is a pioneering biotech startup founded in 2021 with the mission of using innovative DNA modification to combat cancer, as encapsulated in their slogan "Modifying DNA to Eradicate Cancer." The company is developing a groundbreaking oncology therapeutics platform that targets DNA defects in various cancer cells, aiming to revolutionize traditional oncology drug development. Their distinctive approach involves irreparably modifying tumor DNA while sparing healthy cells, achieved through a new class of small molecules directly targeting DNA, sidestepping the need to engage protein targets. This strategy has been successfully tested on a wide range of tumor types in both controlled environments and living organisms, affirming its promise. The founding team comprises esteemed scientists, clinicians, and biotech entrepreneurs. Their core technology, jointly discovered by Seth Herzon and Ranjit Bindra, brings in-depth expertise in synthetic chemistry, DNA repair, and translational research in oncology. Situated at the heart of New Haven, CT’s burgeoning biotech hub, Modifi Bio operates within the Elm City BioScience Center, a cutting-edge facility designed to support emerging biotechnology companies, conveniently located near the Yale School of Medicine. Notably, the startup recently secured a $4.30M seed round investment on 16 October 2023, with significant contributions from Connecticut Innovations, HighCape Partners, Ironwood Capital Connecticut, Pathway Bioventures, National Brain Tumor Society, Sontag Family Trust, and the BrightEdge Fund. This backing underscores investor confidence in Modifi Bio's potential to make a meaningful impact in the biotechnology and health and wellness industries, holding the promise of addressing unmet needs in cancer treatment.

Business keywords: biotech, oncology therapeutics, DNA modification, cancer treatment, small molecules, tumor DNA repair, biotech hub, Yale University, translational research, New Haven, scientific innovation, startup, clinical research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $4.30M 7
Connecticut Innovations, HighCape Partners +5
16 Oct 2023
Grant $2.40M 1
National Cancer Institute
25 Oct 2022
Seed Round $6.40M 2
Connecticut Innovations, National Brain Tumor Society
28 Jul 2022

Modifi Bio Alternatives & Competitors

View All Alternatives
Modifi Bio vs

Biotech company creating a new class of precision immuno-oncology medicines that enable normal immun...

Series A
19 employees
Biotechnology, Health and Wellness
Modifi Bio vs

Nothing remains concealed

5 employees
Biotechnology, Health and Wellness
Modifi Bio vs
Sensei Bio
Sensei Bio United States

We follow the immune system’s teachings to discover new treatments that inspire the body to fight ca...

Series B
32 employees
Biotechnology, Health Care

FAQ About Modifi Bio

Modifying DNA to Eradicate Cancer
Modifi Bio was founded in 2021.
Modifi Bio operates in Biotechnology and Health and Wellness. Its work centres on biotech, oncology therapeutics, DNA modification and cancer treatment.
Modifi Bio has approximately 10 employees.
Modifi Bio has completed 3 funding rounds, raising a total of $13.10M. The latest funding stage is Seed.
Top alternatives and competitors to Modifi Bio include Normunity, Amaroq Therapeutics, Sensei Bio, Nouscom , Oniria Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Modifi Bio and Normunity are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Modifi Bio, https://bouncewatch.com/company/modifi-bio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout